Skip to content

A pilot randomised masked study of ILM peeling with the new Grieshaber Sharkskin forceps as compared to the existing Grieshaber finesse forceps: the PRECISE study

Peeling of the ILM from the retinal surface with finesse forceps; the PRECISE study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN70557873
Enrollment
66
Registered
2019-09-06
Start date
2019-10-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular holes Eye Diseases Macular holes

Interventions

Only patients who have been placed on the waiting list for primary macular hole surgery will be approached. The study will be explained to them and if they are eligible and agree to participate, they

Sponsors

The Newcastle Upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Primary idiopathic macular hole of any size and less than 12-month duration 2. Other previous treatments (gas, OCP) allowed 3. Full comprehension of study requirements at time of consent (at discretion of clinician) 4. Aged 50 years or older

Exclusion criteria

Exclusion criteria: 1. ILM peeling not planned 2. MH secondary to other causes including trauma, previous retinal detachment 3. Previous vitrectomy surgery 4. Previous significant macular disease affecting visual acuity (mild early or intermediate AMD allowed) 5. Advanced glaucoma 6. Known vision affecting optic nerve disease 7. Diabetic retinopathy of more than R1 including previously treated PDR 8. Significant intraocular inflammation 9. Myopia > -6 dioptres or axial length > 26mm 10. Amblyopia of less than ~6/18 11. Conditions affecting ability to perform visual fields or imaging 12. Participation in any other clinical/interventional trial that may impact study findings

Design outcomes

Primary

MeasureTime frame
Recruitment and retention rate recorded as the number of eligible participants who consent to participate in the study over a four-month recruitment period and complete patient schedule in adherence to protocol

Secondary

MeasureTime frame
1. Inner retinal changes measured by standard visual acuity assessments, eye imaging and recording of any adverse events post-surgery at 3 weeks, 3 month and 6-month time points 2. Surgeon perception of device performance during ILM procedure measured by the study questionnaire completed immediately after surgery

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026